BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38423707)

  • 1. Regulation and standardization of herbal drugs: Current status, limitation, challenge's and future prospective.
    Indrayanto G
    Profiles Drug Subst Excip Relat Methodol; 2024; 49():153-199. PubMed ID: 38423707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future development of global regulations of Chinese herbal products.
    Fan TP; Deal G; Koo HL; Rees D; Sun H; Chen S; Dou JH; Makarov VG; Pozharitskaya ON; Shikov AN; Kim YS; Huang YT; Chang YS; Jia W; Dias A; Wong VC; Chan K
    J Ethnopharmacol; 2012 Apr; 140(3):568-86. PubMed ID: 22373513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique issue in the standardization of Chinese materia medica: processing.
    Zhao Z; Liang Z; Chan K; Lu G; Lee EL; Chen H; Li L
    Planta Med; 2010 Dec; 76(17):1975-86. PubMed ID: 21049396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The historical development of pharmacopoeias and the inclusion of exotic herbal drugs with a focus on Europe and Brazil.
    Tabajara de Oliveira Martins D; Rodrigues E; Casu L; Benítez G; Leonti M
    J Ethnopharmacol; 2019 Aug; 240():111891. PubMed ID: 30999013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of historical changes in traditional Chinese medicine based on an Indonesian collection of Chinese materia medica from c. 1870.
    Jia Y; Lei L; Luo X; Zhao Z; Wang M; van Andel T
    J Ethnopharmacol; 2021 Apr; 269():113714. PubMed ID: 33352236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current status and development strategy of ISO/TC 249 standards for Chinese materia medica].
    He YL; Guo LP; Ge Y; Tan Y; Kang CZ; Xu XT; Lyu CG; Yang LH; Yuan QJ
    Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3675-3680. PubMed ID: 35850822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inheritance on and innovation of traditional Chinese medicine (TCM) flavor theory and TCM flavor standardization principle flavor theory in Compendium of Materia Medica].
    Zhang W; Zhang RX; Li J
    Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4928-31. PubMed ID: 27245045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Features and development trends in international standardization of Chinese materia medica in ISO/TC 249.
    Xu XT; Shi YH; Sang Z; Zhou H
    Pharmacol Res; 2021 May; 167():105519. PubMed ID: 33636352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and Comparison Analysis of WHO Monographs on Selected Medicinal Plants and ISO Standards of Chinese Materia Medica.
    Yang JY; Sang Z; Wang R; Shi YH; Huang YR
    Chin J Integr Med; 2023 Jun; 29(6):540-548. PubMed ID: 35508858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Back to the roots: A quantitative survey of herbal drugs in Dioscorides' De Materia Medica (ex Matthioli, 1568).
    Staub PO; Casu L; Leonti M
    Phytomedicine; 2016 Sep; 23(10):1043-52. PubMed ID: 27444350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation on pattern of quality control for Chinese materia medica based on famous-region drug and bioassay--the work reference].
    Yan D; Xiao X
    Zhongguo Zhong Yao Za Zhi; 2011 May; 36(9):1249-52. PubMed ID: 21842660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Traditional Chinese medicine health care from "long term taking" drugs in Shen Nong's Classic of Materia Medica].
    Yu Q; Zhou P; Zhang JJ; Wang LY; Zhuang PW; Zhang YJ
    Zhongguo Zhong Yao Za Zhi; 2023 Feb; 48(3):835-840. PubMed ID: 36872248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pragmatic Historical Assessment Tool: A New Systematic Framework for the Collation and Evaluation of Documented Empirical Effectiveness and Safety of Traditional Plant Medicines in the European Materia Medica.
    Clair S; Kirk R; Coulter ID; Saller R
    Complement Med Res; 2023; 30(4):340-353. PubMed ID: 37279716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rise of traditional Chinese medicine and its materia medica: a comparison of the frequency and safety of materials and species used in Europe and China.
    Williamson EM; Lorenc A; Booker A; Robinson N
    J Ethnopharmacol; 2013 Sep; 149(2):453-62. PubMed ID: 23832055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current situation and research strategy of quality control of health food containing Chinese materia medica].
    Dai YT; Jin RN; Sun R; Wang JB; Zhang GM; Chen SL
    Zhongguo Zhong Yao Za Zhi; 2019 Mar; 44(5):880-884. PubMed ID: 30989844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbal Products Regulations in a Few Countries-A Brief Overview.
    Bhat BB; Udupa N; Sreedhar D
    Curr Drug Discov Technol; 2019; 16(4):368-371. PubMed ID: 30394210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic study on confused species of Chinese materia medica in the Hong Kong market.
    Zhao Z; Yuen JP; Wu J; Yu T; Huang W
    Ann Acad Med Singap; 2006 Nov; 35(11):764-9. PubMed ID: 17160189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis on the current quality standards of Chinese materia Medica used in COVID-19 prevention and treatment.
    Shi YH; Huang YF; Wang WY; Yang L; Zhou H; Sang Z
    Pharmacol Res; 2020 Oct; 160():105074. PubMed ID: 32653649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current standards for seeds and seedlings of Chinese materia medica and analysis].
    Yao X; Cao HL
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(3):745-756. PubMed ID: 33645043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.